Varenicline and Lorcaserin for Smoking Cessation and Weight Gain Prevention: A Randomized Clinical Trial
Objective: To evaluate the safety and effectiveness of combination varenicline with lorcaserin in preventing post-cessation weight gain. Participants and Methods: We conducted a randomized (varenicline for 12 weeks + lorcaserin for 24 weeks vs varenicline for 12 weeks + placebo for 24 weeks) phase I...
Main Authors: | Ryan T. Hurt, MD, PhD, Ivana T. Croghan, PhD, Darrell R. Schroeder, MS, Doo-Sup Choi, PhD, Karen Fischer, MA, Shawn Fokken, CCRP, Jon O. Ebbert, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454822000042 |
Similar Items
-
Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
by: Jon O Ebbert, et al.
Published: (2010-09-01) -
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
by: Hurt RT, et al.
Published: (2018-09-01) -
Couples’ Use of Online Stress Management and Resiliency Training for Sexual Health Concerns: A Randomized Controlled Trial
by: Jordan E. Rullo, PhD, LP, et al.
Published: (2021-08-01) -
Smoking cessation in Asians: focus on varenicline
by: Xiao D, et al.
Published: (2015-04-01) -
Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey
by: Murawski Judith, et al.
Published: (2007-09-01)